Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06948448

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

Led by Ono Pharmaceutical Co., Ltd. · Updated on 2026-03-27

144

Participants Needed

28

Research Sites

149 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the safety and efficacy of two dose levels of ONO-4578 with Opdivo® when added to mFOLFOX6 and bevacizumab versus SOC as first-line treatment for advanced CRC.

CONDITIONS

Official Title

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically confirmed advanced (locally advanced or metastatic) colorectal cancer not amenable to curative resection
  • ECOG Performance Status of 0-1
  • No prior systemic treatment for advanced local or metastatic colorectal cancer
  • Tumor positive for PD-L1 expression as determined at a central laboratory
  • Adults aged 18 years and older
Not Eligible

You will not qualify if you...

  • High microsatellite instability (MSI-High) or mismatch repair deficient (dMMR) tumor
  • Presence of BRAF V600E mutation
  • Unable to swallow tablets
  • History or complication of interstitial lung disease, pneumonitis, or pulmonary fibrosis
  • Active, known or suspected autoimmune disease
  • Prior treatment with anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibodies, or other drugs targeting immune checkpoint pathways
  • Other protocol-defined exclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 28 locations

1

Mayo Clinic Arizona

Phoenix, Arizona, United States, 85054

Actively Recruiting

2

USC Norris Comprehensive Cancer Center

Los Angeles, California, United States, 90033

Actively Recruiting

3

Rocky Mountain Cancer Centers, LLP

Lone Tree, Colorado, United States, 80124

Actively Recruiting

4

Mayo Clinic Florida

Jacksonville, Florida, United States, 32224

Actively Recruiting

5

The Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States, 43221

Actively Recruiting

6

Thomas Jefferson University, Sidney Kimmel Cancer Center

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

7

Baylor Scott & White Medical Center

Temple, Texas, United States, 76508

Actively Recruiting

8

Virginia Oncology Associates

Norfolk, Virginia, United States, 23502

Actively Recruiting

9

Blue Ridge Cancer Care

Salem, Virginia, United States, 24153

Actively Recruiting

10

Princess Margaret Cancer Centre- University Health Network

Toronto, Ontario, Canada, M5G 2M9

Actively Recruiting

11

CHU Besançon - Hôpital Jean Minjoz

Besançon, Doubs, France

Actively Recruiting

12

CHU Bordeaux - Hôpital Haut-Lévêque

Pessac, Gironde, France

Actively Recruiting

13

Chru De Nantes Hotel-Dieu

Nantes, Loire Atlantique, France

Actively Recruiting

14

Hôpital de la Timone

Marseille, Marseille, France

Actively Recruiting

15

Hôpital Européen Georges Pompidou

Paris, Paris, France

Actively Recruiting

16

Hôpital Saint-Antoine

Paris, Paris, France

Actively Recruiting

17

Centre Leon Berard

Lyon, Rhone, France

Actively Recruiting

18

CHU Poitiers - Hôpital la Milétrie

Poitiers, Vienne, France

Actively Recruiting

19

Istituto Clinico Humanitas

Milan, Italy, Italy

Actively Recruiting

20

Istituto Europeo di Oncologia

Milan, Italy, Italy

Actively Recruiting

21

Kobe City Medical Center General Hospital

Hyōgo, Kobe-shi, Japan

Actively Recruiting

22

National Hospital Organization Osaka National Hospital

Osaka, Osaka-shi, Japan

Actively Recruiting

23

Osaka General Medical Center

Osaka, Osaka-shi, Japan

Actively Recruiting

24

Osaka International Cancer Institute

Osaka, Osaka-shi, Japan

Actively Recruiting

25

Hospital Universitario Reina Sofia

Córdoba, Córdoba, Spain

Actively Recruiting

26

Hospital Universitario 12 de Octubre

Madrid, Madrid, Spain

Actively Recruiting

27

Hospital Universitario Virgen del Rocio

Seville, Sevilla, Spain

Actively Recruiting

28

Hospital General Universitario de Valencia

Valencia, Valencia, Spain

Actively Recruiting

Loading map...

Research Team

N

North America Clinical Trial Support Desk

CONTACT

I

International Clinical Trial Support Desk

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here